FIU990494U0 - New composition - Google Patents

New composition

Info

Publication number
FIU990494U0
FIU990494U0 FI990494U FIU990494U FIU990494U0 FI U990494 U0 FIU990494 U0 FI U990494U0 FI 990494 U FI990494 U FI 990494U FI U990494 U FIU990494 U FI U990494U FI U990494 U0 FIU990494 U0 FI U990494U0
Authority
FI
Finland
Prior art keywords
new composition
composition
new
Prior art date
Application number
FI990494U
Other languages
Finnish (fi)
Swedish (sv)
Inventor
David Philip Elder
Deeb Al Ahmad Khalaf Al
Meneaud Padma
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of FIU990494U0 publication Critical patent/FIU990494U0/en
Application granted granted Critical
Publication of FI4488U1 publication Critical patent/FI4488U1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI990494U 1999-06-22 1999-12-03 Pharmaceutical composition FI4488U1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (2)

Publication Number Publication Date
FIU990494U0 true FIU990494U0 (en) 1999-12-03
FI4488U1 FI4488U1 (en) 2000-07-20

Family

ID=27269749

Family Applications (2)

Application Number Title Priority Date Filing Date
FI990494U FI4488U1 (en) 1999-06-22 1999-12-03 Pharmaceutical composition
FI992609A FI19992609A (en) 1999-06-22 1999-12-03 New composition

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI992609A FI19992609A (en) 1999-06-22 1999-12-03 New composition

Country Status (21)

Country Link
EP (1) EP1064936A1 (en)
AT (1) AT3722U1 (en)
AU (2) AU1573100A (en)
BE (2) BE1012806A3 (en)
CA (1) CA2291542A1 (en)
CH (1) CH690024A5 (en)
DE (2) DE29921300U1 (en)
DK (2) DK199901730A (en)
ES (1) ES2159260B1 (en)
FI (2) FI4488U1 (en)
FR (1) FR2795327A1 (en)
GB (1) GB2351233A (en)
GR (1) GR1003490B (en)
IE (2) IES991108A2 (en)
IT (1) ITMI992549A1 (en)
LU (1) LU90483B1 (en)
NL (2) NL1013750C1 (en)
NO (1) NO995945L (en)
PT (1) PT102384A (en)
SE (1) SE9904404L (en)
WO (1) WO2000078291A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (en) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
HUP0303827A2 (en) * 2000-08-28 2004-04-28 Synthon B.V. Paroxetine compositions and processes for making the same
WO2002018303A2 (en) 2000-08-29 2002-03-07 Ranbaxy Laboratories Limited Synthesis of n,n-dimethyl-3-(4-methyl) benzoyl propionamide, a key intermediate of zolpidem
DE20100529U1 (en) * 2001-01-11 2001-05-10 Synthon Bv Pharmaceutical tablet comprising paroxetine mesylate
CA2361882A1 (en) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquid for oral administration comprising paroxetine
RU2004123621A (en) 2002-02-01 2005-04-10 Пфайзер Продактс Инк. (Us) MEDICINAL FORMS WITH IMMEDIATE RELEASE CONTAINING SOLID DISPERSIONS OF MEDICINES
EP1660496A1 (en) * 2003-07-31 2006-05-31 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (en) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 Paroxetine mesylate capsules and preparation method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5371092A (en) * 1990-11-24 1994-12-06 Beecham Group, P.L.C. Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
WO1998056787A1 (en) * 1997-06-10 1998-12-17 Synthon B.V. 4-Phenylpiperidine compounds
CH689805A8 (en) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Paroxetine methanesulfonate, process for its preparation and pharmaceutical compositions containing it.

Also Published As

Publication number Publication date
EP1064936A1 (en) 2001-01-03
BE1012806A3 (en) 2001-03-06
DK199900435U3 (en) 2000-02-11
GR1003490B (en) 2000-11-30
PT102384A (en) 2000-12-29
DK199901730A (en) 2000-12-23
FI4488U1 (en) 2000-07-20
CA2291542A1 (en) 2000-12-22
DE19958228A1 (en) 2000-12-28
SE9904404D0 (en) 1999-12-03
BE1013166A6 (en) 2001-10-02
ES2159260A1 (en) 2001-09-16
FR2795327A1 (en) 2000-12-29
GB2351233A (en) 2000-12-27
AT3722U1 (en) 2000-07-25
NL1013749C2 (en) 2001-01-08
ITMI992549A1 (en) 2001-06-03
AU727000B3 (en) 2000-11-30
NO995945D0 (en) 1999-12-03
DE29921300U1 (en) 2000-02-10
IES991108A2 (en) 2001-04-04
NL1013750C1 (en) 2000-12-28
CH690024A5 (en) 2000-03-31
ITMI992549A0 (en) 1999-12-03
LU90483B1 (en) 2001-01-31
WO2000078291A1 (en) 2000-12-28
AU1573100A (en) 2001-01-09
IE991107A1 (en) 2001-05-30
GB9928673D0 (en) 2000-02-02
SE9904404L (en) 2000-12-23
ES2159260B1 (en) 2002-05-01
FI19992609A (en) 2000-12-22
NO995945L (en) 2000-12-27

Similar Documents

Publication Publication Date Title
NO20021116D0 (en) New composition
IS6120A (en) composition
NO20021115D0 (en) New composition
FI991485A0 (en) New pharmaceutical composition
ID26186A (en) SAMPO COMPOSITION
ID28694A (en) SAMPO COMPOSITION
ID29430A (en) HERBISIDE COMPOSITION
AR023440A1 (en) ANTITRANSPIRING COMPOSITIONS
ID29785A (en) SAMPO COMPOSITIONS
ATE257691T1 (en) SWEAT-INHIBITING COMPOSITIONS
DE69942892D1 (en) GAS-CREATING COMPOSITION
DE69928862D1 (en) composition
DE69943245D1 (en) GAS-CREATING COMPOSITION
DK199901730A (en) New Composition
DE60020682D1 (en) RESORCINE-CONTAINING COMPOSITION
ID26295A (en) HARD-ULTRAVIOLET COMPOSITION
NO20005483D0 (en) New composition
ID26485A (en) PAROXOXINE COMPOSITION
ID27329A (en) COMPOSITION COMPOSITION
NO20011313L (en) New composition
NO20022845L (en) size composition
DE69939964D1 (en) Gel-shaped composition
ID30320A (en) PIGMED COMPOSITIONS
NO20011312L (en) New composition
NO20021026L (en) New compound F-15078